Skip to main content

Table 3 Number of events in each group

From: Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model

 

IC + CCRT(n = 220)

CCRT + AC (n = 170)

IC + CCRT + AC(n = 339)

P value

Failures

56 (25.5%)

44 (25.9%)

11 (33.0%)

P = 0.225

Deaths

25 (11.4%)

22 (12.9%)

44 (13.0%)

P = 0.992

Locoregional failure

21 (9.5%)

13 (7.6%)

36 (10.6%)

P = 0.549

Distant failures

33 (15.0%)

33 (19.4%)

78 (23.0%)

P = 0.174

  1. Data are n (%) or rate (95% CI). CCRT Concurrent chemoradiotherapy. P values were calculated with the log-rank test
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us